Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T31-484TX2M-4&_user=10&_handle=W-WA-A-A-VB-MsSAYZA-UUA-AUCUUDAWUV-BEUDEDYYV-VB-U&_fmt=summary&_coverDate=04%2F08%2F2003&_rdoc=3&_orig=browse&_srch=%23toc%234933%239999%23999999999%2399999!&_cdi=4933&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=504963306361d96be532678574dd21c7

Go to ScienceDirect® Home Skip Main Navigation Links
 Register or Login:   Password:     Athens Login 
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile Help (Opens new window)
1 of 1 Result ListNo Previous DocumentNo Next Document

Mechanisms of Ageing and Development
Volume 124, Issue 5 , May 2003, Pages 679-696


  This Document
  Abstract
  Full Text + Links
  PDF (670 K)
 
  Actions
  E-mail Article
 


doi:10.1016/S0047-6374(03)00063-0    How to cite or link using doi (opens new window) Cite or link using doi  
Copyright © 2003 Elsevier Science Ireland Ltd. All rights reserved.

 

Analysis of mortality decline along with age and latent congenital defects

 

Josef DolejsCorresponding Author Contact Information, E-mail The Corresponding Author

National Radiation Protection Institute, Pileticka 57, Hradec Kralove 50003, Czech Republic

Received 11 September 2002;  revised 31 January 2003;  accepted 31 January 2003. ; Available online 15 March 2003.


 

Abstract

Mortality from congenital anomalies is inversely proportional to age after the age of 1 year. The theory of congenital individual risk explains this mortality decline. The overall aim of this study is to test whether the theory describes mortality decline for all diseases within the first year of life and after the age of 1. Mortality decline along with age was analyzed in five countries and for all causes of death. The theory of congenital individual risk describes well the real mortality decline for all diseases except malignant neoplasms after the birth. Decline of mortality is due to the dying out of the more impaired individuals. Mortality decline with the first power of age results from the selection before the birth. It is dominant and the frequency of defects decreases proportionally to the value of individual risk of death. In the case of identically probable defects, the selection does not occur and mortality declines with the square of age. Congenital defects were also identified as a cause of death in the case of infectious diseases occurring before the age of 10. Mortality from malignant neoplasms is age-independent within the age period 1–20 years and, contrary to all other diseases, no small subpopulation with a significant individual risk was identified.

Author Keywords: Mortality; Age; Congenital anomaly; Infectious diseases; Theory of congenital individual risk


 

Corresponding Author Contact InformationCorresponding author. Tel.: +420-49-5211487; fax: +420-49-5211227



 

 
  This Document
  Abstract
  Full Text + Links
  PDF (670 K)
 
  Actions
  E-mail Article
 

Mechanisms of Ageing and Development
Volume 124, Issue 5 , May 2003 , Pages 679-696



 

1 of 1 Result ListNo Previous DocumentNo Next Document
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile   Help (Opens new window)


 

Send feedback to ScienceDirect
Software and compilation © 2003 ScienceDirect. All rights reserved.
ScienceDirect® is an Elsevier Science B.V. registered trademark.


Your use of this service is governed by Terms and Conditions. Please review our Privacy Policy for details on how we protect information that you supply.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.